Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002404.SZ
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -2.57 1.82 1.87
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -177.82 -2.01 -0.72
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 5.78 3.81 3.60
Cash 42.55 2.30 1.61
Capex -130.33 -0.09 -0.04
Free Cash Flow 48.47 0.35 0.24
Revenue 18.69 2.17 1.83
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -18.47 0.11 0.14
Operating Margin 9.89 0.06 0.05
ROA -1.89 0.01 0.01
ROE -0.17 0.02 0.02
ROIC -9.01 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002404.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002404.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002404.SZ is permitted for members.